Table 1.
Comparison between the patient, and the control groups
| Patient group (n=36) Mean±SD (minimum–maximum) | Control group (n=31) Mean±SD (minimum–maximum) | p | |
|---|---|---|---|
| Age (year) | 45.58±12.35 (21–60) | 44.21±11.60 (20–60) | 0.68 |
| BMI (kg/m2) | 25.84±4.12 (16.53–33.91) | 24.44±5.63 (17.04–32.12) | 0.12 |
| Qmax (mL/sn) | 26.55±6.29 (15.21–39.39) | 28.21±6.65 (21.25–38.45) | 0.09 |
| Qave (mL/sn) | 12.48±3.62 (7.66–19.51) | 13.25±3.96 (9.21–18.56) | 0.25 |
| MBC (mL) | 370±127 (212–630) | 367±96 (270–550) | 0.65 |
| PVRU (mL) | 46±41 (0–120) | 24±12 (0–70) | <0.001** |
| BWT (mm) (full bladder) | 2.58±0.7 (1–4) | 2.01±0.6 (1–3.4) | <0.05* |
| BWT (mm) empty bladder) | 4.33±1.21 (2.4–8) | 3.25±1.01 (2.2–5.1) | <0.001** |
| OAB-V8 | 23.58±7.98 (8–38) | 3.2±2.5 (0–7) | <0.001** |
| ICIQ-SF | 11.09±3.5 (5.18) | 1.2±0.2 (0–3) | <0.001** |
*
p<0.05 was accepted as the level of statistical significance,
**
p<0.001 was accepted as the level of statistical significance.
BMI: body mass index; MBC: maximum bladder capacity; PVRU: Post-void residual urine; BWT: bladder wall thickness; OAB-V8: Overactive Bladder Version-8; ICIQ-SF: International Consultation on Incontinence Questionnaire-Short Form